Huons Dapagliflozin 5mg (Dapagliflozin Monohydrate Blend)
Dapagliflozin Anhydrous Lactose Mixture 7.635mg
Tablet · Prescription medication
Huons Co., Ltd.
MFDS item code 202005364 · Approved 2020.07.23
This product's status changed to Expired on 2025.07.23. It may no longer be sold, so consult a doctor or pharmacist before taking it.
Improvement of glycemic control in type 2 diabetes mellitus
This medication is used in conjunction with diet and exercise to help control blood sugar levels in patients with type 2 diabetes. It can also be administered as monotherapy, and if blood sugar control is challenging, it can be used in combination with other diabetes medications such as metformin, sulfonylureas, insulin, and sitagliptin to enhance its effectiveness. It allows for a variety of treatment experiences and combinations tailored to the individual patient, supporting appropriate blood sugar management. This medication is used to improve blood sugar control.
Type 2 diabetes mellitus Monotherapy and add-on combination therapy The recommended dose of this medicine is 10mg once daily for monotherapy and add-on combination therapy with other glucose-lowering agents, such as insulin. When this medicine is used in combination with insulin or an insulin secretagogue such as a sulfonylurea, a lower dose of insulin or the insulin secretagogue may be considered to reduce the risk of hypoglycemia. Initial combination therapy For patients who have not previously received diabetes medication, the recommended initial dose of this medicine when administered in combination with metformin is 5mg once daily or 10mg once daily. Special populations Renal impairment - eGFR less than 45 mL/min/1.73m2: Use of this medicine to improve glycemic control is not recommended. - Patients on dialysis: Do not administer this medicine. Hepatic impairment No dose adjustment is necessary in patients with mild or moderate hepatic impairment. For patients with severe hepatic impairment, 5 mg is recommended as the starting dose. If well tolerated, this dose may be increased to 10mg. Elderly (≥ 65 years) Dose adjustment based on age is not recommended. Method of administration This medicine may be taken orally once daily at any time of day, with or without food. The tablet should be swallowed whole.
The efficacy and safety of dapagliflozin in children under 18 years of age have not been established. No relevant data are available.
This medication should not be used in patients who are hypersensitive to the active ingredients or excipients. It should not be administered to patients with type 1 diabetes or diabetic ketoacidosis. This medication contains anhydrous lactose, which should not be given to patients with genetic conditions such as galactose intolerance, Lapp lactase deficiency, or glucose-galactose malabsorption. Patients undergoing dialysis should not use this medication. Patients with reduced fluid volume or renal impairment should use this medication cautiously, as it may cause hypotension or rapid changes in kidney function. Especially in older patients or those taking diuretics and with poor kidney function, blood pressure and kidney function should be monitored frequently. This medication contains Yellow No. 4 and Yellow No. 5 dyes, so patients allergic or hypersensitive to these components should exercise caution. This medication may increase the risk of genital infections and urinary tract infections; if related symptoms appear, immediate treatment should be sought. Due to the risk of hypoglycemia, dosage adjustments may be required when used with insulin or sulfonylureas. During treatment, symptoms such as dizziness, dry mouth, constipation, back pain, and dysuria may occur; if unusual symptoms persist, consult a physician. It is advisable for pregnant or breastfeeding women to avoid this medication and to discontinue it immediately if pregnancy is confirmed. There is no specific antidote for overdose, so it is important to receive symptom-appropriate treatment. This medication does not significantly affect driving or machine operation, but caution is necessary due to potential hypoglycemic symptoms. Store this medication out of reach of children and in its original container.
Vulvovaginitis, balanitis and related genital infections, urinary tract infections, fungal infections, perineal necrosis, hypoglycemia, decreased fluid volume, thirst, diabetic ketoacidosis, dizziness, constipation, dry mouth, lumbar pain, dysuria, polyuria, nocturia, interstitial nephritis, vulvar itching, genital itching, increased hematocrit, decreased renal creatinine clearance in the early stages of treatment, dyslipidemia, increased serum creatinine in the early stages of treatment, increased serum urea, weight loss, rash, angioedema, urosepsis, pyelonephritis, acute kidney injury, renal dysfunction, gastroesophageal reflux disease, upper abdominal pain, diverticulosis, bowel perforation, acute pancreatitis, chronic pancreatitis, hyperglycemia, paresthesia, cerebral infarction, nerve compression, weakness, pain, keratitis, chronic obstructive pulmonary disease, hemoptysis, cerebral hemorrhage, peripheral artery occlusion, angina, myocardial infarction, bile duct stones, cholangitis, alcoholic cirrhosis, depression, suicide attempt, gastric adenocarcinoma, anaphylactic reaction, acute pyelonephritis, chest pain, taste disturbance, drowsiness, tension headache, carpal tunnel syndrome, diabetic neuropathy, coma, neuralgia, peripheral neuropathy, sleep disorders, syncope, tremors, herpes simplex, edema, fever, foreign body sensation, facial swelling, facial pain, warmth, flu-like syndrome, chest discomfort, heavy menstrual bleeding, genital rash, genital edema, uterine bleeding, vaginal bleeding, vulvar discomfort, hair loss, dermatitis, dry skin, allergic dermatitis, contact dermatitis, diabetic foot ulcer, abnormal sweating eczema, nummular eczema, eczema, hyperkeratosis, nail pigmentation, skin lesions, urticaria, cold sweat, arthralgia, musculoskeletal pain, limb pain, muscle weakness, myalgia, osteoarthritis, ligament sprains, diabetic retinopathy, cough, shortness of breath, orthostatic hypotension, palpitations, insomnia, fatty liver, gallbladder polyps, tinnitus
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a tightly sealed container to protect it from air and moisture. It is important to maintain a storage temperature between 1 and 30 degrees Celsius. This will help preserve the medication's effectiveness for a longer period.
Yellow, biconvex, film-coated tablet with a round shape
28 tablets/box [(7 tablets/PTP×4)]
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Dapagliflozin Anhydrous Lactose Mixture 7.635mg
Tablet · Prescription medication
Huons Co., Ltd.
Dapagliflozin Anhydrous Lactose Mixture 7.635mg
Tablet · Prescription medication
International Pharmaceuticals Co., Ltd.

Dapagliflozin Anhydrous Lactose Mixture 15.27mg
Tablet · Prescription medication
International Pharmaceutical Co., Ltd.
Dapagliflozin Anhydrous Lactose Mixture 7.635mg
Tablet · Prescription medication
Shinil Pharmaceutical Co., Ltd.

Dapagliflozin Anhydrous Lactose Mixture 15.27mg
Tablet · Prescription medication
Sinil Pharmaceutical Co., Ltd.
Dapagliflozin Anhydrous Lactose Mixture 7.635mg
Tablet · Prescription medication
Dongwha Pharmaceutical Co., Ltd.

Dapagliflozin Anhydrous Lactose Mixture 15.27mg
Tablet · Prescription medication
Donghwa Pharmaceutical Co., Ltd.
Dapagliflozin Anhydrous Lactose Mixture 7.635mg
Tablet · Prescription medication
Albozen Korea Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.